Skip to main content
. 2021 Aug 16;39:101089. doi: 10.1016/j.eclinm.2021.101089

Fig 2.

Fig 2

Comparison of PUFAR amongst DM and different DR statuses.

PUFAR: serum ω-6/ω-3 polyunsaturated fatty acids ratio; DM: type 2 diabetic retinopathy patients without diabetic retinopathy; DR: type 2 diabetic patients with diabetic retinopathy; NPDR: nonproliferative DR; PDR: proliferative DR. * p < 0·001.